Bexion Pharmaceuticals, based in Covington, KY, is a pioneering biopharmaceutical company focused on delivering breakthroughs in oncology and central nervous system (CNS) disorders.
With their lead compound, BXQ-350, Bexion Pharmaceuticals utilizes its novel S1P reduction properties to develop targeted and differentiated treatments, aiming to revolutionize the field of medicine.
Generated from the website